Inicio>>Signaling Pathways>> Tyrosine Kinase>> VEGFR>>VEGFR-2-IN-6

VEGFR-2-IN-6

Catalog No.GC61600

VEGFR-2-IN-6 (ejemplo 64) es un inhibidor de VEGFR2 (modulador de la angiogénesis), que se extrae de la patente WO 02/059110.

Products are for research use only. Not for human use. We do not sell to patients.

VEGFR-2-IN-6 Chemical Structure

Cas No.: 444731-47-9

Tamaño Precio Disponibilidad Cantidad
5 mg
324,00 $
Disponible
10 mg
538,00 $
Disponible
25 mg
1.020,00 $
Disponible
50 mg
1.576,00 $
Disponible
100 mg
2.318,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

VEGFR-2-IN-6 (example 64) is a VEGFR2 inhibitor (angiogenesis modulator), which is extracted from patent WO 02/059110[1].

[1]. Glaxo Wellcome House, et al. PYRIMIDINEAMINES AS ANGIOGENESIS MODULATORS. Patent WO 02/059110.

Reseñas

Review for VEGFR-2-IN-6

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for VEGFR-2-IN-6

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.